Cargando…
Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway
Cellular immune reactions against non-self-epitopes require activation of cytotoxic CD8(+) T-cells via cross-presentation of MHC class I-restricted peptides by professional antigen presenting cells (pAPCs), with the consequent detection and elimination of cells expressing the same antigens via the e...
Autores principales: | Duvallet, Emilie, Boulpicante, Mathilde, Yamazaki, Takahiro, Daskalogianni, Chrysoula, Prado Martins, Rodrigo, Baconnais, Sonia, Manoury, Bénédicte, Fahraeus, Robin, Apcher, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048765/ https://www.ncbi.nlm.nih.gov/pubmed/27757298 http://dx.doi.org/10.1080/2162402X.2016.1198865 |
Ejemplares similares
-
Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation
por: Apcher, Sebastien, et al.
Publicado: (2010) -
Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance
por: Sroka, Ewa Maria, et al.
Publicado: (2023) -
Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptides
por: Martins, Rodrigo Prado, et al.
Publicado: (2019) -
A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus
por: Voisset, Cécile, et al.
Publicado: (2014) -
Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
por: Sekhar, Kuruva Chandra, et al.
Publicado: (2014)